Page 860 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

838 Index

Smoking Somatic cell Squamous cell carcinoma (SCC) (Continued)
cancer risk and, 14 mutation of, 1 organ transplantation and, 353–354
p53 and, 354
reproduction of, 36
carcinogenesis and, 92
VetBooks.ir Smooth muscle tumor, characteristics of, 139 Somatostatin analogs, for feline acromegaly, papillomavirus and, 353
571
SNP. see Single nucleotide polymorphism
photodynamic therapy and, 169–170
Sodium channel, 296 Somatostatin receptor ligands (SRLs), for in situ
Sodium channel blockade, 296 feline acromegaly, 571 definition of, 357
18 F-sodium fluoride ( F-NaF), 119–121 Somatostatin receptor scintigraphy (SRS), 583 presentation of, 357
18
maximum intensity projection (MIP) Sorafenib, 354 treatment of, 357
image, 120f Spaying/neutering, 92–93 solar exposure and, 352
Soft tissue mass, ultrasonography of, 116f mammary cancer and, 92 non-solar versus, 353
Soft tissue sarcomas (STSs), 221–222, osteosarcoma and, 92 tonsillar, 445, 446f
404–431 Specialized catheters, of interventional viral infection and, 352–353
adipose tissue, tumors of, 407–408 oncology, 175 SRLs. see Somatostatin receptor ligands
infiltrative lipoma, 407–408, 407f Specimen SRS. see Somatostatin receptor scintigraphy
intermuscular lipoma, 407, 407f aspiration of, hemorrhaging from, 130 SRT. see Stereotactic radiation therapy
lipoma, 407 collection of, 126–127 Staging
liposarcoma, 408, 408f preparation of, 126 of skin tumor, 355
clinical staging for, 410 technique for, 126–127 for testicular tumors, 629–630, 630f
diagnostic techniques for, 410 cross-sectioning of, 69–70 Staining jar, 127–128
features of importance and grades for, 68t diagnostic quality of, 129 Standard fractionation, 211
fibrous tissue, tumors of, 404–406 examination/description of, 129 Stem cell, suicide gene delivery by, 256
fibrosarcoma, 405–406 microscopic reporting/evaluation of, 69 Stem cell factor (SCF) receptor, 146
myxosarcoma, 406 shrinkage of, 70 Stents
nodular fasciitis, 404–405 Spermatocytic seminoma, 631 of interventional oncology, 175
pleomorphic sarcoma, 406 Spinal cord tumors, 666–669 of malignant strictures, 175–176
grading system for, 405t biopsy and pathology of, 668 Stereotactic radiation therapy (SRT), 170
history and clinical signs for, 410, 410f cerebrospinal fluid analysis of, 668 for canine adrenocortical tumors, 572
incidence and risk factors for, 404 chemotherapy for, 668 for canine osteosarcoma, 539–540,
lymphatic tissue, tumors of, 408–409 classification of, 666, 666f–667f, 666t 539f–540f
lymphangiosarcoma, 408–409, 409f clinical signs of, 666–667 for feline pituitary-dependent
malignant fibrous histiocytoma as, 406 diagnosis of, 667–668 hyperadrenocorticism, 568–569
needle core biopsy and, 159 epidemiology of, 666 time, dose and fractionation, 213–214
pain caused by, 287t history of, 666–667 Stereotactic radiosurgery (SRS), for canine
pathology and natural history for, 404 imaging of, 667–668 osteosarcoma, 539
peripheral nerves, tumors of, 406–407 pathophysiology of, 666–667 Sterile hemorrhagic cystitis, 15
peripheral nerve sheath tumor, 406–407 prognosis for, 668–669 Steroid, NSAIDs and, 296–297
prognosis for, 416–418, 417f radiation therapy for, 668–669 STIR. see Short-T1 Inversion Recovery
local tumor recurrence, 416–417 surgery for, 668–669 Stochastic model, 10–11
metastasis, 417 treatments of, 668–669 “Stop” signal, 5–6
survival, 417–418 Spindle cell tumors (uveal schwannoma), 682 Stopping rules, 346
skeletal muscle, tumors of, 408 Spleen colony, formation of, 50 Stratification, 344
rhabdomyosarcoma, 408, 409f Splenic/visceral feline mast cell tumor Streptococcus pyogene, 236
treatment for, 410–416 incidence/prevalence of, 396 Streptozocin, for canine insulinoma, 584
chemotherapy, 416 signs of, 396 Streptozotocin, 191–192
radiation therapy for, 413–415, 414t, treatment of, 396, 396f Stress, p53 response to, 38, 38f
415f Spontaneous canine tumor, 11–12 Striated muscle tumor, 140
surgery, 411–413, 411f–414f Sporadic (nonheritable) cancer, heritable “String of pearls”, 144
types of, 405t versus, 1 Stroma, 62
uncertain histogenesis, tumors of, 409–410 Sporadic retinoblastoma, 43 tumor-derived PDGF and, 6
malignant mesenchymoma, 409–410 Squamous cell carcinoma (SCC) Stromal cell-derived growth factor, 54
vascular wall, tumors of the, 406 description/prevalence of, 357 Stromal reaction, 69t
perivascular wall tumor, 406 differentiation of, 133 Stromal tumor, 139
Solar-induced SCC, 352 of eyelid and third eyelid, 675, 676f Strontium plesiotherapy, for nasal planum,
Solid-cystic apocrine ductal adenoma, 359 fine-needle aspiration of, 133f cancer of, 494, 494f
Solitary and extramedullary plasmacytic FIV infection causing, 25 Strontium-90, 524–525
tumors, 749–752, 749f–750f genetic abnormalities in, 354 plesiotherapy, 357
diagnosis, 750–751 of nasal planum, 492 STSs. see Soft tissue sarcomas
history and clinical signs, 750 surgery for, 492–493, 493f Subcutaneous mast cell tumor, 384f
pathology and natural behavior, 750 of oral cavity, 432–434, 434f–435f, 443–444 Subcutaneous tissue, tumor of, 352–366
prognosis, 751–752 canine, 442–443 etiology of, 352–354
therapy, 751 feline, 443–444 incidence of, 352